Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Folfox protocol × 30 days × Clear all

Phase

Status

Recruiting 14 Not yet recruiting 3 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

pembrolizumab 26 Cyclophosphamide 16 Nivolumab 14 Cisplatin 12 Paclitaxel 11 Radiotherapy 10 Carboplatin 10 Surveys and Questionnaires 9 Gemcitabine 9 Standard of Care 8 Ipilimumab 8 Fluorouracil 8 Doxorubicin 8 regorafenib 7 fludarabine 7 Oxaliplatin 7 Cetuximab 7 Trastuzumab 6 Rituximab 6 Radiotherapy, Intensity-Modulated 6 Radiosurgery 6 Prednisone 6 Irinotecan 6 Docetaxel 6 Dexamethasone 6 Capecitabine 6 Blood Specimen Collection 6 olaparib 5 atezolizumab 5 Leucovorin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02359968 2026-03-18

PROTECT

Centre Oscar Lambret

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡